Please join us on Thursday, September 18 2025 from 1:00 PM - 2:00 PM EST for the Understanding The Use of Opioids in Later Life Workshop. This free virtual workshop is for older adults (65+) and their caregivers, where we will discuss:
Please join us on Thursday, September 18 2025 from 1:00 PM - 2:00 PM EST for the Understanding The Use of Opioids in Later Life Workshop. This free virtual workshop is for older adults (65+) and their caregivers, where we will discuss:
Click here to register for this free webinar!
The ongoing overdose crisis in Canada has claimed the lives of over 50,000 people since 2016. Parents and professionals working with youth need to know how to protect not only themselves, but also young people who are using or considering using opioids, stimulants or sedatives for any purpose.
Join us as we explore:
Please join us on Thursday, October 24, 2024 from 1pm–2pm ET for the Understanding Opioids in Later Life Workshop. This free workshop is for older adults (65+) and their caregivers, where we will discuss:
Click here to register for this free presentation on September 10th, 2024 at 12:00PM - 1:30PM.
(12:00-1:00PM presentation with 30 minute Q&A period available afterward)
I wanted to share this information video on the use of fentanyl strips. I find the information very helpful especially when educating clients. Thought someone else find it useful! Link is below
Designed for anyone involved in the care and support of people who use opioids, this one-day event will provide the opportunity to learn about and discuss topics related to opioid use practices, policies, treatments and harm reduction.
Are you a family member or close support of someone who used opioids during the COVID-19 pandemic? Are you interested in participating in research? You may be eligible to share your thoughts about how pandemic public health measures impacted people who use opioids!
For more information and contact details, please see the attached flyer.
Methadone and buprenorphine/naloxone are effective opioid agonist therapies (OAT) for opioid use disorder. But some people don’t achieve the outcomes they hope for. Genetic factors are known to influence a person’s risk of developing opioid use disorder, but there is little research on whether they might influence the likelihood that OAT will be effective.
Researchers investigated whether certain gene variants are associated with treatment outcomes in people receiving methadone or buprenorphine/naloxone for prescription-type opioid use disorder.
This week (March 18), Toronto’s Drug Checking Service released two alerts regarding high-potency synthetic nitazene opioids circulating in the city's unregulated opioid supply.
The following information is summarized from their website:
Alert 1: Two new nitazene opioids identified and circulating
On February 16, the Centre for Addiction and Mental Health (CAMH) held a webinar event to promote the release of the 'Addressing Opioid Stigma in Pharmacies – Strategies for Pharmacy Professionals’ toolkit that provides valuable insights and resources for frontline pharmacy professionals to support people taking opioids to mitigate the negative impacts of stigma.
Le français suit l’anglais
The Centre for Addiction and Mental Health (CAMH) is holding a webinar event to promote the release of a toolkit that provides valuable insights and resources for frontline pharmacy professionals to support people taking opioids to mitigate the negative impacts of stigma.
It is estimated that six million Canadians experience addiction in their lifetime and an average of 20 die from opioid toxicity every day. CAMH has launched free online education to teach you how to use a naloxone kit to help save lives.
The new Opioid Overdose Response Training is an engaging gamified experience for you to practice responding to an opioid overdose in four steps:
Methadone is a first-line treatment for opioid use disorder and its use is associated with reduced morbidity, mortality, blood-born viral infections and social harms. Despite these benefits, methadone remains a poorly understood and stigmatized medication. Comprehensive primary care that includes integrated opioid agonist therapy results in improved preventative health screening and higher client satisfaction.